Taysha Gene Therapies, Inc. (TSHA)
USD 1.26
(7.26%)
USD 1.26
(7.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 192.05 Million USD | 53.24% |
| 2022 | 125.32 Million USD | 5.7% |
| 2021 | 118.57 Million USD | 1464.49% |
| 2020 | 7.57 Million USD | 4952.67% |
| 2019 | 150 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 99.15 Million USD | -48.37% |
| 2024 Q2 | 91.52 Million USD | -7.69% |
| 2023 Q1 | 116.54 Million USD | -7.0% |
| 2023 Q3 | 244.88 Million USD | 106.38% |
| 2023 FY | 192.05 Million USD | 53.24% |
| 2023 Q2 | 118.65 Million USD | 1.81% |
| 2023 Q4 | 192.05 Million USD | -21.57% |
| 2022 Q3 | 100.34 Million USD | -8.47% |
| 2022 FY | 125.32 Million USD | 5.7% |
| 2022 Q4 | 125.32 Million USD | 24.9% |
| 2022 Q2 | 109.62 Million USD | -4.88% |
| 2022 Q1 | 115.25 Million USD | -2.8% |
| 2021 Q4 | 118.57 Million USD | 17.81% |
| 2021 FY | 118.57 Million USD | 1464.49% |
| 2021 Q3 | 100.64 Million USD | 81.79% |
| 2021 Q1 | 19.95 Million USD | 163.32% |
| 2021 Q2 | 55.36 Million USD | 177.42% |
| 2020 FY | 7.57 Million USD | 4952.67% |
| 2020 Q4 | 7.57 Million USD | -34.8% |
| 2020 Q3 | 11.62 Million USD | -42.14% |
| 2020 Q2 | 20.09 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 150 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 72.56 Million USD | -164.662% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -5342.674% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -9718.865% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -400.5% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 60.531% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -47.354% |
| Agenus Inc. | 462.29 Million USD | 58.456% |
| Fortress Biotech, Inc. | 165.93 Million USD | -15.74% |
| GlycoMimetics, Inc. | 6.9 Million USD | -2682.598% |
| Novavax, Inc. | 2.57 Billion USD | 92.534% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -407.926% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1080.944% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -303.058% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | 15.331% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 29.465% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 95.258% |
| AlloVir, Inc. | 45.01 Million USD | -326.651% |
| Aptorum Group Limited | 5.25 Million USD | -3553.54% |
| Ardelyx, Inc. | 130.76 Million USD | -46.874% |
| Bicycle Therapeutics plc | 224.41 Million USD | 14.418% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -47.498% |
| Chimerix, Inc. | 19.74 Million USD | -872.687% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -445.971% |
| CRISPR Therapeutics AG | 346.76 Million USD | 44.615% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -284.653% |
| Precision BioSciences, Inc. | 140.92 Million USD | -36.288% |
| Dyadic International, Inc. | 2.34 Million USD | -8105.281% |
| Elevation Oncology, Inc. | 34.28 Million USD | -460.227% |
| Fortress Biotech, Inc. | 165.93 Million USD | -15.74% |
| GT Biopharma, Inc. | 6.63 Million USD | -2795.477% |
| Alkermes plc | 933.53 Million USD | 79.427% |
| Immix Biopharma, Inc. | 3.72 Million USD | -5060.349% |
| Innoviva, Inc. | 568.55 Million USD | 66.22% |
| IO Biotech, Inc. | 17.55 Million USD | -993.968% |
| Jaguar Health, Inc. | 45.86 Million USD | -318.735% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -46.937% |
| ContextLogic Inc. | 206 Million USD | 6.768% |
| AbCellera Biologics Inc. | 335.77 Million USD | 42.802% |
| Lantern Pharma Inc. | 2.73 Million USD | -6910.193% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -7755.092% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 59.853% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | 18.348% |
| MEI Pharma, Inc. | 8.35 Million USD | -2198.707% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -598.11% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -2806.749% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -24.597% |
| NextCure, Inc. | 14.99 Million USD | -1180.636% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -168.686% |
| ChromaDex Corporation | 26.5 Million USD | -624.525% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -580.426% |
| Incyte Corporation | 1.59 Billion USD | 87.938% |
| Opthea Limited | 264.6 Million USD | 27.416% |
| MiMedx Group, Inc. | 96.33 Million USD | -99.374% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -310.914% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -605.366% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -1486.632% |
| Vaxcyte, Inc. | 167.44 Million USD | -14.696% |
| PDS Biotechnology Corporation | 33.25 Million USD | -477.456% |
| Pharming Group N.V. | 244.07 Million USD | 21.312% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -1510.946% |
| Onconetix, Inc. | 23.18 Million USD | -728.514% |
| Acelyrin, Inc. | 86.35 Million USD | -122.409% |
| PureTech Health plc | 125.58 Million USD | -52.932% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -299.935% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -50.29% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -5342.424% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -2806.749% |
| ESSA Pharma Inc. | 3.49 Million USD | -5395.082% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -31.664% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -4651.534% |
| Seer, Inc. | 39.36 Million USD | -387.888% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -132.986% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1235.677% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -2791.118% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -14682.246% |
| Summit Therapeutics Inc. | 125.25 Million USD | -53.33% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -1926.131% |
| Senti Biosciences, Inc. | 52.57 Million USD | -265.329% |
| ImmuCell Corporation | 18.81 Million USD | -920.764% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -26.76% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -432.634% |
| Precigen, Inc. | 41.64 Million USD | -361.188% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -1864.979% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -2776.397% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -179.246% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 44.745% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -14280.217% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 61.162% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -210.601% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -1950.358% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2045.888% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -561.923% |
| Wave Life Sciences Ltd. | 227.44 Million USD | 15.559% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -39.374% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -1659.731% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | 27.358% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -128.569% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -606.898% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -5853.829% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -160.356% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1114.882% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -1639.696% |
| Soligenix, Inc. | 7.27 Million USD | -2539.994% |
| Century Therapeutics, Inc. | 175.94 Million USD | -9.16% |
| Kura Oncology, Inc. | 51.66 Million USD | -271.757% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -58.356% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -4546.915% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -2803.859% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | 23.967% |
| Autolus Therapeutics plc | 263.9 Million USD | 27.225% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -1732.255% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -116.132% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -309.512% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 45.571% |
| GRI Bio, Inc. | 2.69 Million USD | -7021.135% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -23622.895% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -517.725% |
| IGM Biosciences, Inc. | 220.17 Million USD | 12.772% |
| INmune Bio, Inc. | 18.86 Million USD | -918.222% |
| Heron Therapeutics, Inc. | 256.47 Million USD | 25.118% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -620.886% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -6965.059% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -5754.922% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -228.555% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -99.729% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 27.453% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 76.665% |
| Verastem, Inc. | 71.18 Million USD | -169.8% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -290.55% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -397.841% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -292.498% |
| Histogen Inc. | 5.69 Million USD | -3271.195% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -4279.259% |
| Surrozen, Inc. | 8.14 Million USD | -2257.974% |
| Organovo Holdings, Inc. | 2.74 Million USD | -6888.974% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -61092.323% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -241.557% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1063.136% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -275.823% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -23126.848% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -51.554% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -1676.071% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -27.284% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -7265.999% |
| Apollomics, Inc. | 14.15 Million USD | -1257.006% |
| Amarin Corporation plc | 279.58 Million USD | 31.307% |
| Mesoblast Limited | 188.79 Million USD | -1.726% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1257.485% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -6.233% |
| Synaptogenix, Inc. | 5.52 Million USD | -3373.335% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -2788.944% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -12.903% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2144.393% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -10828.517% |
| Exelixis, Inc. | 678.44 Million USD | 71.692% |
| Better Therapeutics, Inc. | 23.84 Million USD | -705.541% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -17.075% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 67.679% |
| NLS Pharmaceutics AG | 10.68 Million USD | -1698.252% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -11728.967% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -393.377% |
| Gritstone bio, Inc. | 125.91 Million USD | -52.524% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1208.647% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -3674.24% |
| Avid Bioservices, Inc. | 275.66 Million USD | 30.33% |
| Insmed Incorporated | 1.66 Billion USD | 88.443% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -2396.184% |
| MediWound Ltd. | 27.18 Million USD | -606.43% |
| OmniAb, Inc. | 87.4 Million USD | -119.745% |
| Alector, Inc. | 487.66 Million USD | 60.617% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 52.397% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -942.372% |
| Zai Lab Limited | 240.17 Million USD | 20.035% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 69.518% |
| Aura Biosciences, Inc. | 29.22 Million USD | -557.122% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -102.002% |
| Immunic, Inc. | 25.36 Million USD | -657.084% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -177.395% |
| Veracyte, Inc. | 93.71 Million USD | -104.929% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -7239.74% |
| FibroGen, Inc. | 585.72 Million USD | 67.211% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1004.855% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -29308.063% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -3295.958% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 97.492% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -2242.73% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -128.579% |
| TG Therapeutics, Inc. | 169.08 Million USD | -13.586% |
| Galecto, Inc. | 5.89 Million USD | -3157.412% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -2218.409% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 92.665% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -566.356% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1421.726% |
| XBiotech Inc. | 8.39 Million USD | -2187.21% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1208.647% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -261.145% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 47.107% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -614.391% |
| Theravance Biopharma, Inc. | 169 Million USD | -13.641% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 84.201% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 61.621% |
| Vaxxinity, Inc. | 30.94 Million USD | -520.66% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 80.251% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -3084.44% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 74.229% |
| NexImmune, Inc. | 5.08 Million USD | -3677.503% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -51612.467% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -6146.065% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 97.298% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -3626.346% |
| Scopus BioPharma Inc. | 7.45 Million USD | -2476.413% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -630.421% |
| Ainos, Inc. | 7.39 Million USD | -2497.393% |
| Pluri Inc. | 34.11 Million USD | -463.019% |
| Prothena Corporation plc | 135.01 Million USD | -42.247% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | 20.998% |
| Celularity Inc. | 102.92 Million USD | -86.592% |
| Rallybio Corporation | 9.43 Million USD | -1935.365% |
| Cue Biopharma, Inc. | 24.44 Million USD | -685.67% |
| MeiraGTx Holdings plc | 319.99 Million USD | 39.98% |
| Omeros Corporation | 403.25 Million USD | 52.373% |
| Humacyte, Inc. | 114.67 Million USD | -67.476% |
| Immunocore Holdings plc | 228.15 Million USD | 15.823% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -3839.631% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -150.27% |
| Blueprint Medicines Corporation | 918.64 Million USD | 79.093% |
| CalciMedica, Inc. | 4.02 Million USD | -4668.049% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1000.487% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -123.798% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 30.863% |
| Pulmatrix, Inc. | 15.96 Million USD | -1103.139% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1117.631% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -680.529% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | 23.425% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -278.169% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 84.136% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -504.276% |
| Nutriband Inc. | 1.07 Million USD | -17700.873% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -1706.235% |
| Vor Biopharma Inc. | 59.1 Million USD | -224.948% |
| Roivant Sciences Ltd. | 773.95 Million USD | 75.185% |
| Evogene Ltd. | 17.99 Million USD | -967.576% |
| ProKidney Corp. | 29.21 Million USD | -557.369% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -166.824% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -27142.785% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 89.832% |
| CorMedix Inc. | 11.91 Million USD | -1511.551% |
| BioLineRx Ltd. | 50.7 Million USD | -278.796% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -28.501% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -117.158% |
| Atai Life Sciences N.V. | 49.16 Million USD | -290.661% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -516.51% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -969.241% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -54.094% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -3296.834% |
| MediciNova, Inc. | 3.89 Million USD | -4835.228% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -950.698% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -12667.701% |
| GeoVax Labs, Inc. | 3.51 Million USD | -5356.349% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 51.654% |
| Biomea Fusion, Inc. | 30.69 Million USD | -525.797% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 92.944% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1103.214% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -515.548% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -227.273% |
| Absci Corporation | 58.3 Million USD | -229.406% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -908.279% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -499.018% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -160.275% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -119.536% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -468.721% |
| Allakos Inc. | 74.79 Million USD | -156.785% |
| Imunon, Inc. | 8.53 Million USD | -2151.435% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -753.549% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -67.28% |
| BioAtla, Inc. | 48.98 Million USD | -292.065% |
| NLS Pharmaceutics AG | 10.68 Million USD | -1698.252% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -6811.011% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -47.053% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1251.087% |
| XOMA Corporation | 145.58 Million USD | -31.925% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -470.495% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -179.319% |
| aTyr Pharma, Inc. | 31.59 Million USD | -507.833% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -210.656% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -327.126% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -296.796% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -6591.882% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -2254.212% |
| Akari Therapeutics, Plc | 4.58 Million USD | -4089.725% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -983.041% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 88.356% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -47449.69% |
| UroGen Pharma Ltd. | 243.52 Million USD | 21.134% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 40.185% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -6854.661% |
| Orgenesis Inc. | 35.53 Million USD | -440.473% |
| Entera Bio Ltd. | 1.37 Million USD | -13827.266% |
| GH Research PLC | 6.7 Million USD | -2766.095% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -2724.368% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -920.169% |
| Xencor, Inc. | 283.55 Million USD | 32.269% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -6332.616% |
| Replimune Group, Inc. | 113.21 Million USD | -69.641% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -5011.808% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -85.509% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -47449.69% |
| Portage Biotech Inc. | 4.45 Million USD | -4215.888% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -12667.701% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -733.219% |
| OncoCyte Corporation | 49.29 Million USD | -289.584% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -4542.641% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -23982.866% |
| Purple Biotech Ltd. | 10 Million USD | -1819.61% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -3219.34% |
| scPharmaceuticals Inc. | 57.26 Million USD | -235.406% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -1450.344% |
| HilleVax, Inc. | 78.9 Million USD | -143.39% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -3703.109% |
| Tharimmune, Inc. | 1.81 Million USD | -10481.385% |
| Genprex, Inc. | 3.25 Million USD | -5801.805% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -608.201% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -3568.01% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -93131.553% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -53465.213% |
| OKYO Pharma Limited | 7.42 Million USD | -2488.074% |
| Savara Inc. | 37.19 Million USD | -416.393% |
| Curis, Inc. | 57.61 Million USD | -233.363% |
| Daré Bioscience, Inc. | 26.32 Million USD | -629.427% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -389.944% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -13200.346% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -822.508% |
| BeiGene, Ltd. | 2.23 Billion USD | 91.402% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -802.108% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | 26.807% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -802.778% |
| Erasca, Inc. | 78.61 Million USD | -144.313% |
| bluebird bio, Inc. | 424.62 Million USD | 54.77% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -29210.403% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 89.839% |
| DBV Technologies S.A. | 42.8 Million USD | -348.731% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -29210.403% |
| Moderna, Inc. | 4.57 Billion USD | 95.799% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -2645.633% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -11497.645% |
| Molecular Templates, Inc. | 31.17 Million USD | -516.14% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1025.114% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 67.343% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -54.256% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -599.993% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -426.819% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -245.209% |
| MacroGenics, Inc. | 154.2 Million USD | -24.545% |
| RenovoRx, Inc. | 4.46 Million USD | -4200.425% |
| Adicet Bio, Inc. | 37.12 Million USD | -417.395% |
| Prime Medicine, Inc. | 60.78 Million USD | -215.987% |
| Aditxt, Inc. | 28.53 Million USD | -573.139% |
| Adagene Inc. | 45.16 Million USD | -325.193% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -106184.415% |
| Quantum-Si incorporated | 26.63 Million USD | -621.178% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 72.468% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -6212.602% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -67.063% |
| SciSparc Ltd. | 1.59 Million USD | -11941.191% |
| Vericel Corporation | 127.7 Million USD | -50.391% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3351.225% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -125.001% |
| Generation Bio Co. | 171.63 Million USD | -11.902% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -1562.831% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -359.126% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | 23.997% |
| Invivyd, Inc. | 51.71 Million USD | -271.39% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -108.81% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -2852.338% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -154.394% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -18710.676% |
| 2seventy bio, Inc. | 310.12 Million USD | 38.071% |
| ADMA Biologics, Inc. | 193.97 Million USD | 0.989% |
| Clene Inc. | 38.95 Million USD | -393.073% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -431.53% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | 25.263% |
| GeoVax Labs, Inc. | 3.51 Million USD | -5356.349% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -0.943% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -1476.866% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | 3.159% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -1474.909% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -299.196% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -263.462% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 48.072% |
| Evaxion Biotech A/S | 17.61 Million USD | -990.15% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -19.343% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -25.375% |
| Trevena, Inc. | 48.26 Million USD | -297.947% |
| Surrozen, Inc. | 8.14 Million USD | -2257.974% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -789.359% |
| Cingulate Inc. | 10.36 Million USD | -1753.677% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -6883.891% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -415.009% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -5254.968% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1360.51% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 39.453% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -672.896% |
| Clearmind Medicine Inc. | 3.61 Million USD | -5220.127% |
| Kronos Bio, Inc. | 54.2 Million USD | -254.342% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -308.258% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -743.846% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -856.888% |
| Statera Biopharma, Inc. | 22.67 Million USD | -746.945% |
| ImmunityBio, Inc. | 1.09 Billion USD | 82.386% |
| Korro Bio, Inc. | 51.75 Million USD | -271.11% |
| Kineta, Inc. | 7.22 Million USD | -2559.333% |
| BioVie Inc. | 9.7 Million USD | -1879.534% |
| Codexis, Inc. | 49.94 Million USD | -284.529% |
| Celularity Inc. | 102.92 Million USD | -86.592% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -99.546% |
| Celcuity Inc. | 51.45 Million USD | -273.288% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -55537.41% |
| Cibus, Inc. | 206.11 Million USD | 6.821% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -352.165% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -629.173% |
| IN8bio, Inc. | 8.77 Million USD | -2089.432% |
| Kodiak Sciences Inc. | 213.59 Million USD | 10.082% |
| Annexon, Inc. | 47.11 Million USD | -307.609% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -114.491% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -99.287% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1303.002% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 92.623% |
| Eyenovia, Inc. | 19.78 Million USD | -870.952% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -8.454% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2400.417% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -696.95% |
| Arcellx, Inc. | 339.75 Million USD | 43.471% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -1514.196% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | 21.782% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -1908.334% |
| Moolec Science SA | 13.94 Million USD | -1277.211% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -345.071% |
| Geron Corporation | 146.12 Million USD | -31.432% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -280.07% |
| Royalty Pharma plc | 6.29 Billion USD | 96.95% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -382.846% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -65135.423% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -7706.3% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1.534% |
| Humacyte, Inc. | 114.67 Million USD | -67.476% |
| Structure Therapeutics Inc. | 29.05 Million USD | -561.103% |
| 89bio, Inc. | 59.96 Million USD | -220.293% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -625.757% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -15958.278% |
| Genelux Corporation | 8.42 Million USD | -2180.962% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -2701.298% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -40.888% |
| Notable Labs, Ltd. | 4.42 Million USD | -4238.31% |
| Liquidia Corporation | 73.13 Million USD | -162.595% |
| Mustang Bio, Inc. | 17.61 Million USD | -990.056% |
| Immunovant, Inc. | 48.95 Million USD | -292.313% |
| Quantum-Si incorporated | 26.63 Million USD | -621.178% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -400.37% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -6089.397% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -160.025% |
| Acasti Pharma Inc. | 11.55 Million USD | -1561.824% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -749.519% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -6965.059% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -420.804% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -13992.389% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -3050.541% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -673.332% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -728.403% |
| PepGen Inc. | 34.63 Million USD | -454.581% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -1481.497% |
| United Therapeutics Corporation | 1.18 Billion USD | 83.754% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -2649.957% |
| Solid Biosciences Inc. | 38.45 Million USD | -399.394% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2144.393% |
| Immuneering Corporation | 12 Million USD | -1499.361% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -61092.323% |
| Silo Pharma, Inc. | 1.56 Million USD | -12138.621% |
| Belite Bio, Inc | 4.21 Million USD | -4460.841% |
| XOMA Corporation | 145.58 Million USD | -31.925% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -7810.091% |
| Bionomics Limited | 10.15 Million USD | -1790.563% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -793.662% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -738.201% |
| uniQure N.V. | 624.01 Million USD | 69.223% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1252.99% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -106184.415% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -12.853% |
| Forte Biosciences, Inc. | 3.66 Million USD | -5138.871% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -73602.813% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -2746.554% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2400.417% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1004.855% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -1717.345% |
| Altimmune, Inc. | 16.54 Million USD | -1061.097% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 68.908% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -738.201% |
| Compugen Ltd. | 55.77 Million USD | -244.342% |
| Peak Bio, Inc. | 20.75 Million USD | -825.426% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -73.865% |
| Benitec Biopharma Inc. | 4.96 Million USD | -3770.556% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -21.676% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -155.483% |
| Zura Bio Limited | 21.29 Million USD | -802.015% |
| PolyPid Ltd. | 17.46 Million USD | -999.479% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -70.871% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -155.483% |
| Instil Bio, Inc. | 99.8 Million USD | -92.44% |
| argenx SE | 444.95 Million USD | 56.836% |
| Immunome, Inc. | 28.65 Million USD | -570.169% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -2203.67% |
| Verona Pharma plc | 58.84 Million USD | -226.4% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1227.002% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1192.53% |
| CervoMed Inc. | 2.59 Million USD | -7298.911% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -3840.439% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1407.985% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -1723.037% |
| Moolec Science SA | 13.94 Million USD | -1277.211% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -8095.292% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -245.455% |
| AnaptysBio, Inc. | 364.28 Million USD | 47.279% |
| Design Therapeutics, Inc. | 11.95 Million USD | -1506.365% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1414.167% |
| NeurAxis, Inc. | 1.91 Million USD | -9940.941% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -393.365% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1340.464% |
| Achilles Therapeutics plc | 19.08 Million USD | -906.219% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1227.002% |
| 180 Life Sciences Corp. | 5.38 Million USD | -3465.056% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -714.215% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -743.846% |
| Nutriband Inc. | 1.07 Million USD | -17700.873% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -527.678% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1223.527% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 52.138% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -491.436% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1371.803% |
| Palisade Bio, Inc. | 2.73 Million USD | -6911.939% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -3556.139% |
| Beam Therapeutics Inc. | 478.38 Million USD | 59.853% |
| Neurogene Inc. | 36.54 Million USD | -425.478% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 51.739% |
| AEON Biopharma, Inc. | 159.88 Million USD | -20.119% |
| Sesen Bio, Inc. | 30.98 Million USD | -519.859% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -639.79% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -2426.329% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | 1.881% |
| Athira Pharma, Inc. | 30.05 Million USD | -538.976% |
| Vaccinex, Inc. | 5.94 Million USD | -3132.195% |
| HCW Biologics Inc. | 15.05 Million USD | -1175.962% |
| XOMA Corporation | 145.58 Million USD | -31.925% |
| Nektar Therapeutics | 267.04 Million USD | 28.081% |
| Arvinas, Inc. | 644.6 Million USD | 70.205% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -983.041% |
| Merus N.V. | 102.15 Million USD | -88.013% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -31.231% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -101.91% |
| Rezolute, Inc. | 11.73 Million USD | -1536.756% |
| Clene Inc. | 38.95 Million USD | -393.073% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -6645.043% |
| BeyondSpring Inc. | 48.26 Million USD | -297.889% |
| Synlogic, Inc. | 32.89 Million USD | -483.849% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1214.289% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -11653.794% |
| Peak Bio, Inc. | 20.75 Million USD | -825.426% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -202.647% |
| Krystal Biotech, Inc. | 39.71 Million USD | -383.6% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 49.008% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -92.888% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -44283.051% |
| MannKind Corporation | 721.36 Million USD | 73.376% |
| Ikena Oncology, Inc. | 22.33 Million USD | -759.893% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -9106.951% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -87.208% |
| Gossamer Bio, Inc. | 249.14 Million USD | 22.914% |
| CohBar, Inc. | 1.03 Million USD | -18480.683% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -1696.772% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -908.279% |
| Legend Biotech Corporation | 589.93 Million USD | 67.444% |
| Mural Oncology plc | 37.92 Million USD | -406.373% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -44.8% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -8267.286% |
| Disc Medicine, Inc. | 22.87 Million USD | -739.593% |
| Champions Oncology, Inc. | 28.03 Million USD | -585.062% |
| REGENXBIO Inc. | 262.22 Million USD | 26.76% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -5617.085% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -1432.288% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1329.886% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -805.716% |
| Vaxart, Inc. | 34.02 Million USD | -464.458% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -841.952% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -573.131% |
| Cellectis S.A. | 249.57 Million USD | 23.046% |
| Longeveron Inc. | 5.33 Million USD | -3498.595% |
| Repare Therapeutics Inc. | 41.81 Million USD | -359.258% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 92.015% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -218.144% |
| Revolution Medicines, Inc. | 262.39 Million USD | 26.807% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -9015.187% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2126.49% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -1527.464% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1267.635% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -8828.731% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 96.271% |
| Denali Therapeutics Inc. | 122.96 Million USD | -56.191% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3351.225% |
| Veru Inc. | 32.81 Million USD | -485.313% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -2695.997% |
| Cingulate Inc. | 10.36 Million USD | -1753.677% |
| Passage Bio, Inc. | 39.26 Million USD | -389.168% |
| Context Therapeutics Inc. | 4.19 Million USD | -4481.824% |
| Exicure, Inc. | 8.54 Million USD | -2146.543% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -550.864% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -1731.556% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -771.362% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -17.837% |
| Nuvalent, Inc. | 31.82 Million USD | -503.516% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -2918.992% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -204.746% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -966.983% |
| OmniAb, Inc. | 87.4 Million USD | -119.745% |
| Anew Medical, Inc. | 8.24 Million USD | -2230.28% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -401.597% |
| Lipocine Inc. | 2.63 Million USD | -7198.027% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -631.033% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -377.611% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -620.886% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -122.923% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -3455.953% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -132.101% |
| Ocugen, Inc. | 23.98 Million USD | -700.805% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -313.854% |
| Q32 Bio Inc. | 233.12 Million USD | 17.617% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2018.432% |
| Alumis Inc. Common Stock | 53.5 Million USD | -258.972% |
| Equillium, Inc. | 27.95 Million USD | -586.973% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | 7.036% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -3313.336% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -3031.551% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -22.076% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -176.608% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -1825.538% |
| Dominari Holdings Inc. | 4.63 Million USD | -4043.625% |
| Edesa Biotech, Inc. | 1.84 Million USD | -10328.602% |
| vTv Therapeutics Inc. | 29.56 Million USD | -549.565% |
| Bio-Techne Corporation | 744.34 Million USD | 74.198% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -52.307% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 44.243% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -373.338% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -563.249% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -107.944% |
| Nkarta, Inc. | 105.6 Million USD | -81.872% |
| BioCardia, Inc. | 4.59 Million USD | -4084.248% |
| Iterum Therapeutics plc | 32.66 Million USD | -488.014% |